Literature DB >> 34081114

Reply to the letter regarding "Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients-a report of the PET/RANO group": 18F-fluciclovine and target volume delineation.

Norbert Galldiks1,2,3, Maximilian Niyazi4,5, Jörg-Christian Tonn6,5, Karl-Josef Langen2,3,7.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34081114      PMCID： PMC8328023          DOI： 10.1093/neuonc/noab098

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  11 in total

1.  Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma.

Authors:  David M Schuster; John R Votaw; Peter T Nieh; Weiping Yu; Jonathon A Nye; Viraj Master; F DuBois Bowman; Muta M Issa; Mark M Goodman
Journal:  J Nucl Med       Date:  2007-01       Impact factor: 10.057

2.  Phase IIa clinical study of [18F]fluciclovine: efficacy and safety of a new PET tracer for brain tumors.

Authors:  Akihide Kondo; Hisato Ishii; Shigeki Aoki; Masaru Suzuki; Hidekazu Nagasawa; Kazuo Kubota; Ryogo Minamimoto; Atsushi Arakawa; Masato Tominaga; Hajime Arai
Journal:  Ann Nucl Med       Date:  2016-07-14       Impact factor: 2.668

3.  18F-FACBC PET/MRI in Diagnostic Assessment and Neurosurgery of Gliomas.

Authors:  Anna Karlberg; Erik Magnus Berntsen; Håkon Johansen; Anne Jarstein Skjulsvik; Ingerid Reinertsen; Hong Yan Dai; Yiming Xiao; Hassan Rivaz; Per Borghammer; Ole Solheim; Live Eikenes
Journal:  Clin Nucl Med       Date:  2019-07       Impact factor: 7.794

4.  Fluorine-18-Labeled PET Radiotracers for Imaging Tryptophan Uptake and Metabolism: a Systematic Review.

Authors:  Flóra John; Otto Muzik; Sandeep Mittal; Csaba Juhász
Journal:  Mol Imaging Biol       Date:  2020-08       Impact factor: 3.488

5.  Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors.

Authors:  T M Shoup; J Olson; J M Hoffman; J Votaw; D Eshima; L Eshima; V M Camp; M Stabin; D Votaw; M M Goodman
Journal:  J Nucl Med       Date:  1999-02       Impact factor: 10.057

6.  Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group.

Authors:  Norbert Galldiks; Maximilian Niyazi; Anca L Grosu; Martin Kocher; Karl-Josef Langen; Ian Law; Giuseppe Minniti; Michelle M Kim; Christina Tsien; Frederic Dhermain; Riccardo Soffietti; Minesh P Mehta; Michael Weller; Jörg-Christian Tonn
Journal:  Neuro Oncol       Date:  2021-06-01       Impact factor: 12.300

7.  Diagnostic Performance and Safety of Positron Emission Tomography Using 18F-Fluciclovine in Patients with Clinically Suspected High- or Low-grade Gliomas: A Multicenter Phase IIb Trial.

Authors:  Toshihiko Wakabayashi; Toshihiko Iuchi; Naohiro Tsuyuguchi; Ryo Nishikawa; Yoshiki Arakawa; Takashi Sasayama; Keisuke Miyake; Tadashi Nariai; Yoshitaka Narita; Naoya Hashimoto; Osamu Okuda; Hiroshi Matsuda; Kazuo Kubota; Kimiteru Ito; Yoichi Nakazato; Kan Kubomura
Journal:  Asia Ocean J Nucl Med Biol       Date:  2017

8.  18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors.

Authors:  Laure Michaud; B J Beattie; T Akhurst; M Dunphy; P Zanzonico; R Finn; A Mauguen; H Schöder; W A Weber; A B Lassman; R Blasberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-15       Impact factor: 9.236

9.  Clinical value of fluorine-18α-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET.

Authors:  Keishi Horiguchi; Masahiko Tosaka; Tetsuya Higuchi; Yukiko Arisaka; Kenichi Sugawara; Junko Hirato; Hideaki Yokoo; Yoshito Tsushima; Yuhei Yoshimoto
Journal:  EJNMMI Res       Date:  2017-05-31       Impact factor: 3.138

10.  18F-Fluciclovine PET to distinguish treatment-related effects from disease progression in recurrent glioblastoma: PET fusion with MRI guides neurosurgical sampling.

Authors:  Fraser Henderson; Steven Brem; Donald M O'Rourke; MacLean Nasrallah; Vivek P Buch; Anthony J Young; Robert K Doot; Austin Pantel; Arati Desai; Stephen J Bagley; S Ali Nabavizadeh
Journal:  Neurooncol Pract       Date:  2019-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.